Search
for
Sort by
Research 91–120 of 1000+
- Cell-Based Model Systems for Validation of Various Efficacy-Based Claims for Cosmetic Ingredients
- The Potential of Resveratrol-Rich Peanut Callus Extract in Promoting Hair Growth and Preventing Hair Loss
- The Hormonal Background of Hair Loss in Non-Scarring Alopecias
- Health Benefits and Safety of Red Pigmented Rice (Oryza sativa L.): In Vitro, Cellular, and In Vivo Activities for Hair Growth Promoting Treatment
- Safety of Alopecia Treatments in Patients with Breast Cancer and High-Risk Women: A Review
- Cosmeceutical Potentials of Equisetum debile Roxb. ex Vaucher Extracts
- Minoxidil Acts as an Antiandrogen: A Study of 5α-reductase Type 2 Gene Expression in a Human Keratinocyte Cell Line.
- In Vitro Main Pathways of Steroid Action in Cultured Hair Follicle Cells: Vascular Approach
- Kinetic analysis of LY320236: competitive inhibitor of type I and non-competitive inhibitor of type II human steroid 5α-reductase
- Anti-androgenic activities of Ganoderma lucidum
- Sample collecting methods for bacterial community structure analysis of scalp hair: non-invasive swabbing versus intrusive hair shaft cutting
- Antiaging Activity of Peptide Identified from Fermented <i>Trapa Japonica</i> Fruit Extract in Human Dermal Fibroblasts
- Role of the ACTH/MC2R System in the Hair Cycle in Mice
- <i>Pinus thunbergii</i> bark extract rich in flavonoids promotes hair growth in dorsal skin by regulating inflammatory cytokines and increasing growth factors in mice
- Apoptotic dysregulation mediates stem cell competition and tissue regeneration
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Development of a Spectrophotometric Method to determination Minoxidil by Diazotization-Coupling reaction with Sulfanilic acid
- Simultaneous Quantification of Dutasteride and Silodosin Using a Stability-Indicating RP-HPLC Approach
- Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024
- UV Spectrophotometric Stability Indicating Method Development and Validation for the Determination of Finasteride Bulk and Dosage Form.
- A missense mutation in Lama3 causes androgen alopecia
- 11α-Hydroxyprogesterone, a potent 11β-hydroxysteroid dehydrogenase inhibitor, is metabolised by steroid-5α-reductase and cytochrome P450 17α-hydroxylase/17,20-lyase to produce C11α-derivatives of 21-deoxycortisol and 11-hydroxyandrostenedione in vitro
- A new label-free screen for steroid 5α-reductase inhibitors using LC-MS
- The 5α-reductase inhibitor finasteride is not associated with alterations in sleep spindles in men referred for polysomnography
- DEVELOPING AND VALIDATING AN HPLC METHOD TO QUANTIFY SIMULTANEOUSLY DUTASTERIDE AND THEIR RELATED MOLECULES (DUTASTERIDE ACID, 2,5 BIS- (TRI FLUORO METHYL)-ANILINE AND DUTASTERIDE 17 α-EPIMER) IN CAPSULES
- Steroid 5α-Reductase as a Novel Therapeutic Target for Schizophrenia and Other Neuropsychiatric Disorders
- Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men